Mr. Milinazzo has 15 years of experience in interventional cardiology, and will replace Ofir Paz, who announced his plans to step down in September.
Formerly, Mr. Milinazzo was the president and CEO of Orthofix International, where he worked with spine devices and orthopedic stem cell therapy.
More Articles on Devices:
Soft Tissue Regeneration Receives Market Approval for Rotator Cuff Repair Device
Alphatec Spine Receives FDA Clearance for 2 Cervical, Fixation Devices
Zimmer Recall Labeled High Risk by FDA
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.